A patient developing gastroparesis while taking one of these medications may have their symptoms attributed to the drug rather than to an underlying motility problem, which can delay diagnosis further
February 14, 2020
In this work, we show that GLP-1 acting in the OB modulates insulin secretion via the sympathetic nervous system
Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) increased throughout the first quarter of 2024 (+20.9% increase in March 2024 compared to December 2023)
Thus, gut, brain, and kidney signals, a tripartite communication network, are integrated through multiple signaling mechanisms involving vagal signaling, microbiota-derived metabolites, immune-mediated crosstalk, and neuroendocrine regulation
Access this article Similar content being viewed by others References International Diabetes Federation (IDF)